Target intelligence / Profile preview

Ubiquitin conjugating enzyme E2 C pseudogene 4 (UBE2CP4)

Target
UBE2CP4
Molecular classification
Pseudogene
01

Overview

UBE2CP4 is a **pseudogene** located in the human genome, classified as a non-functional gene remnant related to the UBE2C family (ubiquitin conjugating enzymes)[1]. Unlike canonical UBE2C, which encodes an enzyme involved in the ubiquitination pathway—a critical process for protein degradation and cell cycle regulation—UBE2CP4 does not produce a functional protein and has no assigned molecular or therapeutic function[1][2]. Pseudogenes such as UBE2CP4 may influence cellular function via regulatory non-coding RNA actions in rare cases, but there_is currently no published evidence supporting a biological or clinical role for UBE2CP4 specifically[5]. It is not considered a molecular target, receptor, enzyme, transporter, or therapeutic target for drug development. UBE2CP4 is a pseudogene, not a valid molecular target for drug development or therapy. There is no additional information beyond its genomic annotation[1].

Other names
UBE2C pseudogene 4

Beyond the preview

Go deeper on Ubiquitin conjugating enzyme E2 C pseudogene 4 (UBE2CP4).

Explore the evidence, development activity, and competitive landscape with Gosset’s full data platform.

Drug pipeline

Full profile access

Explore the programs pursuing this target and their development progress.

  • Drug candidates
  • Developers
  • Development stage

Clinical trials

Full profile access

Follow the clinical studies evaluating therapies directed at this target.

  • Trial design
  • Status
  • Readouts

Competitive landscape

Full profile access

Compare approaches across drug candidates, modalities, and indications.

  • Programs
  • Modalities
  • Indications

Literature & evidence

Full profile access

Investigate the research and source evidence behind target biology and development.

  • Publications
  • Sources
  • Analysis

Patents

Full profile access

Explore patent activity around therapies and technologies addressing this target.

  • Patents
  • Assignees
  • Technologies

Research & analysis

Full profile access

Connect target biology, drug development, and emerging evidence in your research.

  • Biology
  • Development news
  • Analysis

Bring the full picture into focus.

See how Gosset can support your research on Ubiquitin conjugating enzyme E2 C pseudogene 4 (UBE2CP4).

Explore the full profile

Gosset Free

Get started with Gosset.

Enter your work email and we’ll be in touch with next steps.

Work email preferred.

Book a call